APA (7th ed.) Citation

Müller, P. C., Frey, M. C., Ruzza, C. M., Nickel, F., Jost, C., Gwerder, C., . . . Kessler, U. (2021). Neoadjuvant chemotherapy in pancreatic cancer: An appraisal of the current high-level evidence. Pharmacology, 106(3/4), . https://doi.org/10.1159/000510343

Chicago Style (17th ed.) Citation

Müller, Philip C., Michael C. Frey, Claudio M. Ruzza, Felix Nickel, Christian Jost, Christoph Gwerder, Thilo Hackert, Kaspar Z’graggen, and Ulf Kessler. "Neoadjuvant Chemotherapy in Pancreatic Cancer: An Appraisal of the Current High-level Evidence." Pharmacology 106, no. 3/4 (2021). https://doi.org/10.1159/000510343.

MLA (9th ed.) Citation

Müller, Philip C., et al. "Neoadjuvant Chemotherapy in Pancreatic Cancer: An Appraisal of the Current High-level Evidence." Pharmacology, vol. 106, no. 3/4, 2021, https://doi.org/10.1159/000510343.